v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 29, 2024   117,116,311    
Beginning balance at Dec. 29, 2024 $ 446,145,000 $ 117,000 $ 1,321,386,000 $ (875,358,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ (48,197,000)     (48,197,000)
Exercise of stock options (in shares) 323,369 323,369    
Exercise of stock options $ 2,679,000 $ 1,000 2,678,000  
Issuance of common stock related to Spyce milestone achievement (in shares)   242,722    
Issuance of common stock related to Spyce milestone achievement 4,709,000   4,709,000  
Issuance of common stock related to restricted shares (in shares)   524,848    
Shares repurchased for employee tax withholding (in shares)   (9,745)    
Shares repurchased for employee tax withholding (259,000)   (259,000)  
Stock-based compensation expense 18,221,000   18,221,000  
Ending balance (in shares) at Jun. 29, 2025   118,197,505    
Ending balance at Jun. 29, 2025 423,298,000 $ 118,000 1,346,735,000 (923,555,000)
Beginning balance (in shares) at Mar. 30, 2025   117,658,484    
Beginning balance at Mar. 30, 2025 432,754,000 $ 118,000 1,333,033,000 (900,397,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (23,158,000)     (23,158,000)
Exercise of stock options (in shares)   112,661    
Exercise of stock options 996,000   996,000  
Issuance of common stock related to Spyce milestone achievement (in shares)   242,722    
Issuance of common stock related to Spyce milestone achievement 4,709,000   4,709,000  
Issuance of common stock related to restricted shares (in shares)   183,732    
Shares repurchased for employee tax withholding (in shares)   (94)    
Shares repurchased for employee tax withholding (3,000)   (3,000)  
Stock-based compensation expense 8,000,000   8,000,000  
Ending balance (in shares) at Jun. 29, 2025   118,197,505    
Ending balance at Jun. 29, 2025 423,298,000 $ 118,000 1,346,735,000 (923,555,000)
Beginning balance (in shares) at Dec. 28, 2025   118,448,417    
Beginning balance at Dec. 28, 2025 356,125,000 $ 118,000 1,365,430,000 (1,009,423,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ 99,539,000     99,539,000
Exercise of stock options (in shares) 11,599 11,599    
Exercise of stock options $ 59,000 $ 1,000 58,000  
Issuance of common stock related to Spyce milestone achievement (in shares)   242,722    
Issuance of common stock related to Spyce milestone achievement 1,604,000   1,604,000  
Issuance of common stock related to restricted shares (in shares)   331,327    
Shares repurchased for employee tax withholding (in shares)   (296)    
Shares repurchased for employee tax withholding (688,000)   (688,000)  
Stock-based compensation expense 10,982,000   10,982,000  
Ending balance (in shares) at Jun. 28, 2026   119,033,769    
Ending balance at Jun. 28, 2026 467,621,000 $ 119,000 1,377,386,000 (909,884,000)
Beginning balance (in shares) at Mar. 29, 2026   118,816,743    
Beginning balance at Mar. 29, 2026 488,931,000 $ 119,000 1,372,426,000 (883,614,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (26,270,000)     (26,270,000)
Exercise of stock options (in shares)   10,599    
Exercise of stock options 51,000   51,000  
Issuance of common stock related to restricted shares (in shares)   206,485    
Shares repurchased for employee tax withholding (in shares)   (58)    
Shares repurchased for employee tax withholding (269,000)   (269,000)  
Stock-based compensation expense 5,178,000   5,178,000  
Ending balance (in shares) at Jun. 28, 2026   119,033,769    
Ending balance at Jun. 28, 2026 $ 467,621,000 $ 119,000 $ 1,377,386,000 $ (909,884,000)